The New Kid on the Stock-Trading Block:

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
The New Kid on the Stock-Trading Block: Citigroup

Source: Dow Jones News

By Christina Rexrode

After years of cost-cutting, Citigroup Inc. is starting to invest--in equities trading, an unexpected choice for a classic bond shop.

The New York bank led by CEO Michael Corbat is pushing to become more competitive in dealing stocks and related derivatives, as well as providing support services for hedge funds and other clients to trade those securities.

Citigroup has a lot of ground to make up, and the stakes are high. The bank's traditional engines of trading revenue, bonds and currencies, are slumping due to high regulatory costs and low interest rates. Meanwhile, Citigroup ranks by some estimates a distant ninth place in global stock trading, behind rivals like Goldman Sachs Group Inc. and Morgan Stanley.

Turning the equities business around is an important test for Mr. Corbat, a 55-year-old former Salomon Brothers trader who spent his formative years dealing bonds.

"Each time they've tried to ramp it up, it's ended in frustration," says UBS Group AG analyst Brennan Hawken.

Boosting a Wall Street equities business requires a mix of enhancements involving electronic trading systems, analyst research, relationships with big investors, risk management of hedge-fund lending, and fast-paced buying and selling that unfolds on dozens of platforms. The next reading on Mr. Corbat's efforts will come Jan. 15, when Citigroup reports earnings for the fourth quarter and full year 2015.

In recent years, the CEO's pruning of various consumer-related businesses has left the bank more dependent on Wall Street activities such as trading, which accounted for about 20% of its revenue in the first nine months of the year.

Like other U.S. investment banks, Citigroup hopes to take ground from European rivals under pressure from shareholders to shrink their riskier businesses.

The job falls to Derek Bandeen, a former Morgan Stanley stock trader and Duke University fencing-team captain. Mr. Bandeen, 52 years old, has run the stock-trading division for more than seven years, a period in which Citigroup has failed to pick up much market share against larger rivals. Over the first three quarters of 2015, its ninth-place ranking among global investment banks in equities revenue compared with a second-place ranking in bond trading, according to data compiled by UBS.

A Canadian who spent one teenage summer working in the Arctic for a telephone company, the London-based Mr. Bandeen has set a goal of getting the New York bank into the top six in the equities business, while smoothing some of the recent volatility in the division's results. In the third quarter, Citigroup ranked No. 7.

"I'd like to be No. 1," says Mr. Bandeen. "But I don't think we're going there any time soon."

While Citigroup declines to discuss how much it is spending to overhaul equities, Mr. Bandeen points to a string of new hires from banks like Deutsche Bank AG, UBS and market operator Chi-X Global as a sign of its commitment. The bank has increased focus on getting business from hedge funds, where Citigroup hasn't been traditionally as strong.

In coming months, Citigroup will also roll out a new electronic platform known as Optimus 2.0, designed to get clients to trade more frequently with the firm.

Citigroup once thought about exiting the equities business because the unit was too small, but decided to keep it and make it more profitable, James Forese, Citigroup's president and a former head of equities, said at a recent conference. Mr. Forese has told colleagues that he sees similarities between stock trading and the airline business, where smaller players can be more successful.

Citigroup and analysts say the bank is better positioned than some peers to grow in equities because it already can meet a new 5% capital requirement for U.S. banks known as the supplemental leverage ratio. Citigroup's most recent reading: 6.9%

"They have a far better shot now than before," said Macquarie Securities analyst David Konrad. Citigroup is also more focused than before the financial crisis, when it pushed into stocks as part of a strategy to get bigger in everything.

In the months after Mr. Bandeen was hired in 2008, the bank accepted three rounds of U.S. government aid to get through the crisis. Since then, in a push to become smaller, it shed its wealth-management division, a giant subprime consumer lender, and branches from Boston to Hungary.

Bond trading remains a focus. In the first nine months of 2015, Citigroup's fixed-income division produced more than three times the revenue of its equities traders. At eight other global investment banks, the gap between divisions was much smaller, with fixed-income divisions generating only about 29% more revenue than equities overall.

Equities have been growing in importance, though. Over the first three quarters of 2015, stock-trading revenue on Wall Street rose 12% from 2014, while fixed-income desks suffered a 10% decline, UBS analysts said.

This week, banks will start reporting results for the fourth quarter that could show fixed-income revenue declining another 1%, compared with a gain of about 3% in equities, UBS projects.

Banks traditionally used their lending expertise in fixed income to make lucrative bets while accommodating client orders. Stock trading long ago moved to a more electronic game marked by speed, low cost, and efficiency.

Banks don't usually hold big positions in equities, which is why regulators generally view the business as less risky.

In recent months, Mr. Bandeen has hired more research analysts and encouraged a greater focus on European stock derivatives, something Citigroup executives feel the bank is in a strong position to do because of its footprint in about 100 countries.

Write to Christina Rexrode at christina.rexrode@wsj.com

(END) Dow Jones Newswires

January 10, 2016 05:44 ET (10:44 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Gentherm's Q2 2025 Results Highlight Strong Performance & Future

Updated Category News Views 132

Gentherm's Financial Performance for Second Quarter 2025 Gentherm, a global innovator in thermal management technologies, reported outstanding financial outcomes for the second quarter of 2025. The company's revenue reached $375 million, underscoring its strength in the automotive sector, particularly within Climate and Comfort Solutions. Record Achievements and New...

Continue Reading
DEALMining Surpasses 6.8 Million Users with Exciting Rewards

Updated Category News Views 237

DEALMining Achieves Major User Milestone In a significant accomplishment, DEALMining has proudly announced that its user base has exceeded 6.8 million globally, marking its status as one of the fastest-growing compliant cloud mining platforms in the world. This impressive growth showcases DEALMining's successful outreach across more than 200 countries and regions, as the...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
Vivoryon Therapeutics to Share Insights on 2024 Performance

Updated Category News Views 176

Vivoryon Therapeutics N.V. Set to Report Financial Outcomes Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the entirety of 2024, along with insights into its operational achievements. The highly anticipated announcement is scheduled for April 29, 2025, aiming to shed light on the company’s progress in...

Continue Reading
Navigating Economic Trends: Insights for Savvy Investors

Updated Category News Views 110

Understanding the Economic Climate In finance, a stable economy is often described as a "Goldilocks" economy, where conditions are ideal for investments to flourish. Lately, we have witnessed an economy that consistently surpasses expectations, putting worries about downturns to rest. The Search for Economic Balance Investors are keen to find that sweet spot where...

Continue Reading